Shandong Realcan Pharmaceutical Co Ltd Capital Reinvestment Ratio
Shandong Realcan Pharmaceutical Co Ltd capital reinvestment ratio. Shandong Realcan Pharmaceutical Co Ltd (002589) has a Capital Reinvestment Ratio of 2.12x as of June 2025, meaning it reinvests 2% of its operating cash flow (CN¥24.86 Million) in capital expenditures (CN¥52.73 Million). See 002589 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shandong Realcan Pharmaceutical Co Ltd (2009–2025)
Capital reinvestment ratio of Shandong Realcan Pharmaceutical Co Ltd from 2009 to 2025. This chart tracks Shandong Realcan Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 9 annual periods. See financial flexibility index of Shandong Realcan Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
Shandong Realcan Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2009–2025)
Shandong Realcan Pharmaceutical Co Ltd capital reinvestment ratio by year from 2009 to 2025. For the full cash flow conversion analysis, see Shandong Realcan Pharmaceutical Co Ltd cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.95x | CN¥13.76 Million | CN¥26.82 Million | ▲ +180.4% |
| 2024 | 0.70x | CN¥160.44 Million | CN¥111.53 Million | ▼ -80.8% |
| 2023 | 3.62x | CN¥82.47 Million | CN¥298.38 Million | ▲ +1007.0% |
| 2022 | 0.33x | CN¥523.07 Million | CN¥170.96 Million | ▼ -68.6% |
| 2021 | 1.04x | CN¥442.95 Million | CN¥461.09 Million | ▼ -14.5% |
| 2020 | 1.22x | CN¥414.96 Million | CN¥505.39 Million | ▲ +172.9% |
| 2019 | 0.45x | CN¥2.09 Billion | CN¥934.87 Million | ▼ -16.5% |
| 2010 | 0.53x | CN¥70.56 Million | CN¥37.72 Million | ▲ +70.6% |
| 2009 | 0.31x | CN¥61.38 Million | CN¥19.23 Million | — |